|
|
|
| Effect of Vitamin AD Drops combined with glucocorticoid inhalation in the treatment of mycoplasma pneumonia in children and its effect on immune function |
| JANG Yuanyuan1 PAN Jianrong2 ZHANG Heng3▲ |
1.Department of Pediatric Internal Medicine, Wuxi Maternal and Child Health Care Hospital Wuxi School of Medical, Jiangnan University, Jiangsu Province, Wuxi 214002, China;
2.Department of Pediatric Respiratory, Wuxi Children’s Hospital, Jiangsu Province, Wuxi 214000, China;
3.Department of Child Healthcare, Wuxi Maternal and Child Health Care Hospital Wuxi School of Medical, Jiangnan University, Jiangsu Province, Wuxi 214002, China |
|
|
|
|
Abstract Objective To observe the effect of Vitamin AD Drops combined with glucocorticoid inhalation in the treatment of mycoplasma pneumonia in children and its effect on immune function. Methods A total of 92 children with mycoplasma pneumonia in children admitted to Wuxi Maternal and Child Health Hospital, Jiangsu Province from January 2018 to October 2019 were selected as study subjects. They were divided into two groups by odd-even number labeling method, with 46 cases in each group. Both groups were treated with Azithromycin, the glucocorticoid group were treated with inhalation glucocorticoid, and combined group were treated with Vitamin AD Drops based on glucocorticoid group, the course of treatment was two weeks. The clinical effect of two groups was compared; symptoms and signs improvement time, immune function, regulatory T cells/helper T cells 17 (Treg/Th17) were compared between two groups; patients were followed up for one year and the recurrence was recorded in both groups. Results In glucocorticoid group, three cases were shed, and 43 cases were enrolled. The disappearance time of fever, asthma, cough, and wet rales in combination group was shorter than that in glucocorticoid group (P＜0.05); there was no significant difference in the time of lung shadow disappearance between two groups (P＞0.05). After treatment, CD3+, CD4+, and CD4+/CD8+ in both groups were higher than those before treatment, and CD8+ was lower than that before treatment, and CD3+, CD4+, and CD4+/CD8+ in combination group were higher than those in glucocorticoid group, and CD8+ was lower than that in glucocorticoid group (P＜0.05). After treatment, Treg and Treg/Th17 were higher than those before treatment, and Th17 was lower than that before treatment, and Treg and Treg/Th17 in combination group were higher than those in glucocorticoid group, and Th17 was lower than that in glucocorticoid group (P＜0.05). There was no significant difference in clinical efficacy between two groups (P＞0.05). The recurrence rate of combined group was lower than that of glucocorticoid group, and the treatment time when recurrence was shorter than that of glucocorticoid group (P＜0.05). Conclusion Vitamin AD Drops combined with glucocorticoids can promote the disappearance of symptoms and signs and reduce recurrence of mycoplasma pneumonia in children, which may be related to the regulation of immune function.
|
|
|
|
|
|
[1] 王书玲，侯江红.清金降火汤加减联合阿奇霉素对痰湿闭阻型小儿支原体肺炎患者的临床疗效[J].中成药，2020，42（4）：908-912.
[2] 杨钦，德吉卓嘎，谌亮，等.莨菪碱注射液辅助阿奇霉素序贯治疗小儿支原体肺炎的疗效研究[J].中国现代医学杂志，2020，30（21）：74-77.
[3] 梦娇，王玺.阿奇霉素联合甲泼尼龙治疗小儿肺炎支原体肺炎的效果及胸部CT征象变化[J].影像科学与光化学，2022，40（6）：1550-1554.
[4] 韩聪莉，党媛媛，田庆玲，等.糖皮质激素联合阿奇霉素对迁延性小儿支原体肺炎血清炎症因子及临床改善情况的研究[J].新疆医科大学学报，2020，43（7）：901-904.
[5] 郑文博，王伟.赖氨肌醇维B12口服对营养不良患儿机体营养改善情况及免疫功能的影响[J].陕西医学杂志，2022，51（4）：481-483.
[6] 蒋芹，国志，郭苗苗，等.维生素A、D辅治肺炎支原体肺炎患儿及对血清T细胞亚群、IL-13、CysLTs的影响[J].临床和实验医学杂志，2022，21（23）：2547-2550.
[7] 亚美.诸福棠实用儿科学[M].北京：人民卫生出版社，2015.
[8] 国家卫生健康委员会.儿童肺炎支原体肺炎诊治指南（2023版）[EB/OL].[2023-02-15].http：//www.nhc.gov.cn/yzygj/ s7659/202302/8536e7db5cc7443eba13601e58d58861/files/ b75c01f656c04653bfed27f0bb88b550.doc.
[9] 李志萍，陈惠军，常绍鸿，等.儿童支原体肺炎的Th17/ Treg细胞平衡变化及 Notch信号通路作用研究[J].中华医院感染学杂志，2020，30（7）：1048-1052.
[10] 贺宇杉，杨梅，钱素云.细胞因子对难治性肺炎支原体肺炎的预测作用[J].中华儿科杂志，2021，59（5）：422-425.
[11] 马晓林，丁臻博，黄永坤.儿童肺炎支原体对大环内酯类抗生素耐药现状及机制研究进展[J].国际药学研究杂志，2020，47（10）：804-808.
[12] 杜春艳，张妮妮，江逊.小剂量与常规剂量糖皮质激素辅助治疗小儿难治性肺炎支原体肺炎合并肺外并发症临床效果及安全性观察[J].贵州医药，2021，45（7）：1097- 1098.
[13] 刘凤.小剂量糖皮质激素辅助治疗小儿支原体肺炎有效性和安全性分析[J].世界复合医学，2021，7（3）：160- 162.
[14] Lee YC，Chang CH，Lee WJ，et al. Altered chemokine profile in Refractory Mycoplasma pneumoniae pneumonia infected children [J]. J Microbiol Immunol Infect，2021，54（4）：673-679.
[15] Zhai YY，Wu SZ，Yang Y，et al. An analysis of 20 clinical cases of refractory mycoplasma pneumonia in children [J]. Ann Palliat Med，2020，9（5）：2592-2599.
[16] Zhou H，Chen X，Li J. Effect of Methylprednisolone Plus Azithromycin on Fractional Exhaled Nitric Oxide and Peripheral Blood Eosinophils in Children with Refractory Mycoplasma Pneumoniae Pneumonia [J]. J Coll Physicians Surg Pak，2022，32（1）：33-36.
[17] Qu X，Xu Z，Lin X. Effects of different doses of methylprednisolone on TNF-α，IL-6，and IL-13 in serum and bronchoalveolar lavage fluid of children with severe mycoplasma pneumoniae pneumonia [J]. J Biol Regul Homeost Agents，2020，34（5）：1889-1895.
[18] Kim SH，Yoo HW，Kim YM，et al. Wells’ syndrome related to Mycoplasma pneumoniae in a 5-year-old boy [J]. Pediatr Int，2020，62（5）：635-637.
[19] Shakoor H，Feehan J，Al Dhaheri AS，et al. Immune- boosting role of vitamins D，C，E，zinc，selenium and omega-3 fatty acids：Could they help against COVID-19? [J]. Maturitas，2021，143：1-9.
[20] Ali N. Role of vitamin D in preventing of COVID-19 infection，progression and severity [J]. J Infect Public Health，2020，13（10）：1373-1380.
[21] 刘艳芹，王玉珍，高翠云.肺炎支原体肺炎患儿血清维生素A、维生素D水平变化及临床意义[J].中国临床研究，2020，33（5）：669-671，675.
[22] Goddek S. Vitamin D3 and K2 and their potential contribution to reducing the COVID-19 mortality rate [J]. Int J Infect Dis，2020，99：286-290.
[23] Murai IH，Fernandes AL，Sales LP，et al. Effect of a Single High Dose of Vitamin D3 on Hospital Length of Stay in Patients With Moderate to Severe COVID-19：A Randomized Clinical Trial [J]. JAMA，2021，325（11）：1053-1060.
[24] James PT，Ali Z，Armitage AE，et al. The Role of Nutrition in COVID-19 Susceptibility and Severity of Disease：A Systematic Review [J]. J Nutr，2021，151（7）：1854-1878.
[25] Mansur JL，Tajer C，Mariani J，et al. Vitamin D high doses supplementation could represent a promising alternative to prevent or treat COVID-19 infection [J]. Clin Investig Arterioscler，2020，32（6）：267-277. |
|
|
|
